HopeStage
Back to all studies
RecruitingNCT07389473

Eye movement patterns and prescribed mental health medication use

About this titleRead the official source — NCT07389473
Observational studyAges 18–65United StatesADHD
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What will I do during this study?

Adults ages 18–65 who have taken a prescribed psychiatric medicine for more than three months may be eligible for this Philadelphia study. Researchers use an eye-movement device and compare participants taking these medicines with a control group not taking them. The study is evaluating the device; it does not establish that eye movements can identify a medicine or its effects. Other eligibility criteria apply.

Listed locations
PhiladelphiaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 17, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
50
Sponsor
Gaize
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT07389473
Official title
Show the full official title

An Observational Study to Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device

Recruitment & locations

Currently recruiting

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Gaize.

Does this study involve medication?

Yes. The study involves medication, including Prescription Psychotropic Medications.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies